Santhera Licenses AGAMREE

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The company has out‑licensed the rights to AGAMREE in several territories, including North America, China, Japan, South Korea, Australia, and New Zealand.